ctrl K

Watchlist Price Alert

Albany Molecular Research... (AMRI)

NASDAQ: AMRI · Real-Time Price · USD

undefined

null (null%)

At close: Jun 28, 2019, 10:07 PM

Albany Molecular Research Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Revenue	680.82M	628.69M	570.45M	505.54M	457.38M	426.12M
Cost of Revenue	530.57M	481.06M	437.65M	377.58M	334.3M	316.75M
Gross Profit	150.25M	147.63M	132.8M	127.96M	123.08M	109.37M
Operating Income	-20.55M	-12.53M	-18.76M	-7.11M	8.56M	8.27M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-67.85M	-59.22M	-59.96M	-47.71M	-24.3M	-14.42M
Net Income	-59.77M	-70.8M	-70.17M	-52.98M	-33.72M	-10.14M
Selling & General & Admin	141.69M	130.97M	122.14M	112.01M	95.93M	84.52M
Research & Development	16.23M	16.25M	16.05M	13.98M	11.25M	8.15M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	157.92M	147.22M	138.18M	126M	107.17M	92.67M
Interest Expense	51.26M	45.62M	39.92M	33.73M	27.34M	23.45M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	701.36M	641.22M	589.21M	512.64M	448.81M	417.85M
Income Tax Expense	-8.93M	11.58M	10.21M	5.26M	9.42M	-4.27M
Shares Outstanding (Basic)	42.45M	42.45M	42.45M	36.99M	34.83M	34.83M
Shares Outstanding (Diluted)	42.45M	42.45M	42.45M	36.99M	34.83M	34.83M
EPS (Basic)	-1.48	-1.85	-1.89	-1.48	-0.98	-0.29
EPS (Diluted)	-1.48	-1.85	-1.89	-1.48	-0.98	-0.3
EBITDA	59.21M	52.43M	36.67M	30.81M	41.54M	43.81M
EBIT	-16.59M	-13.6M	-20.04M	-13.98M	3.04M	9.04M
Depreciation & Amortization	76.65M	66.03M	56.71M	44.79M	38.5M	34.77M